FDA News Digest for September 26, 2005

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: Message

FDA News Digest

September 26, 2005

__________________________________________________

 

IN THIS WEEK'S ISSUE

 

--  FDA Says Inamed's Silicone Breast Implants Are 'Approvable'

--  First Pediatric Generic AIDS Drug Approved for U.S. Marketing

--  Throckmorton Chosen Deputy Director of FDA Drugs Center

--  Recalls/Safety Alerts

--  Congressional Testimony

--  Public Meetings

--  Question of the Week

___________________________________________________

 

FDA Says Inamed's Silicone Breast Implants Are 'Approvable'

 

FDA has issued an "approvable" letter to Inamed Corp. for its application to market silicone gel-filled breast implants. An approvable letter is one of several steps in the FDA review process for new products. The letter does not mean that FDA has approved the implants for marketing at this time. Inamed is the second implant maker in recent weeks to receive an approvable letter. Mentor Corp. received one in August.

http://www.fda.gov/bbs/topics/NEWS/2005/NEW01233.html

 

First Pediatric Generic AIDS Drug Approved for U.S. Marketing

 

FDA has approved several generic versions of zidovudine, a drug that treats HIV and AIDS. Previously, these products had only received tentative approval because patent or market exclusivity prevented full marketing approval. But those patents have now expired, clearing the way for the full approval. Zidovudine is in a class of drugs that helps keep the AIDS virus from replicating and is typically used with other drugs to treat HIV infection.

http://www.fda.gov/bbs/topics/NEWS/2005/NEW01232.html

 

Throckmorton Chosen Deputy Director of FDA Drugs Center

 

FDA has named Douglas Throckmorton, M.D., deputy director of the agency's Center for Drug Evaluation and Research. He has served in that position in an acting capacity since May 2004 and has held other management positions within the drugs center since 1997. Throckmorton also serves as the founding chair of the recently established FDA Drug Safety Oversight Board.

http://www.fda.gov/bbs/topics/NEWS/2005/NEW01234.html

 

To view an archive of past FDA news releases, go to

http://www.fda.gov/opacom/hpnews.html.

 

To access the RSS feed of FDA news releases, go to

http://www.fda.gov/bbs/topics/news/rssPress.xml.

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

___________________________________________________

 

RECALLS/SAFETY ALERTS

 

All injectable products made by Central Admixture Pharmacy Services Inc.

Reason for recall: possible sterility problems

http://www.fda.gov/medwatch/safety/2005/safety05.htm#CAPS

 

For a list of recalls, market withdrawals, and safety alerts involving FDA-regulated

products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.

 

To access the RSS feed of FDA recalls information, go to

http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml.

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

___________________________________________________

 

CONGRESSIONAL TESTIMONY

 

Sept. 13 -- FDA Office of Drug Evaluation II Director Robert J. Meyer, M.D., appeared before the House Committee on Government Reform.

Subject: prescription drug abuse

http://www.fda.gov/ola/2005/drugabuse0913.html

 

To view an archive of past testimony by FDA officials, go to

http://www.fda.gov/ola/listing.html.

____________________________________________________

 

PUBLIC MEETINGS
 

Sept. 27 -- General Hospital and Personal Use Devices Panel of the Medical Devices Advisory Committee

Under discussion: FDA's Critical Path initiative

Location: Gaithersburg, Md.

http://www.fda.gov/oc/advisory/accalendar/2005/cdrh12520d092705.html

 

Sept. 29 -- Blood Products Advisory Committee

Under discussion: a proposed treatment for chronic iron overload due to blood transfusions

Location: Rockville, Md.

http://www.fda.gov/oc/advisory/accalendar/2005/cber19516d092905.html

 

Sept. 29 -- Research Review Subcommittee of the Cellular, Tissue and Gene Therapies Advisory Committee

Under discussion: the research program at FDA's Office of Cellular, Tissue and Gene Therapies

Location: Bethesda, Md.

http://www.fda.gov/oc/advisory/accalendar/2005/cber12389d092905.html

 

For a list of FDA meetings, seminars, and other public events, go to

http://www.fda.gov/opacom/hpmeetings.html.

__________________________________________________

QUESTION OF THE WEEK

 

Can the symptoms of foodborne illness be mistaken for something else?

Yes. Foodborne illness often shows itself as flu-like symptoms such as nausea, vomiting, diarrhea, or fever, so many people may not recognize that the illness is caused by bacteria or other pathogens in food.

The Centers for Disease Control and Prevention (CDC) reports that many of the intestinal illnesses commonly referred to as stomach flu are actually caused by foodborne pathogens. People do not associate these illnesses with food because the onset of symptoms often occurs two or more days after the contaminated food was eaten.                                                                                                                                                        ___________________________________________________

Thanks for subscribing to FDA News Digest. Our next posting will be October 3.

 

To subscribe to or unsubscribe from this list, go to

http://list.nih.gov/cgi-bin/wa?SUBED1=fda-newsdigest-l&A=1.


[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux